Besides the role of PTX3 as a biomarker, recent studies have demonstrated that PTX3 increased expression in prostate cancer biopsies colocalized with C1q deposits and correlated with augmented C3aR and C5aR receptors. Here, PTX3 is linked to prostate cancer.